Nuvation Bio Inc.
NUVB
$2.88
-$0.02-0.69%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 900.35% | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 900.35% | -- | -- | -- | -- |
| Cost of Revenue | 672.16% | -- | -- | -- | -- |
| Gross Profit | 4,393.18% | -- | -- | -- | -- |
| SG&A Expenses | 225.25% | 245.46% | 142.64% | 59.17% | 19.45% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -55.68% | 587.05% | 501.57% | 443.60% | 407.11% |
| Operating Income | 58.23% | -575.33% | -493.68% | -441.51% | -405.76% |
| Income Before Tax | 60.27% | -780.50% | -649.24% | -542.39% | -464.87% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 60.27% | -780.50% | -649.24% | -542.39% | -464.87% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 60.27% | -780.50% | -649.24% | -542.39% | -464.87% |
| EBIT | 58.23% | -575.33% | -493.68% | -441.51% | -405.76% |
| EBITDA | 58.39% | -575.95% | -494.32% | -442.14% | -406.41% |
| EPS Basic | 70.25% | -645.37% | -551.03% | -473.22% | -410.13% |
| Normalized Basic EPS | 70.26% | -645.65% | -552.06% | -475.20% | -412.99% |
| EPS Diluted | 70.15% | -640.38% | -551.75% | -473.88% | -410.74% |
| Normalized Diluted EPS | 70.26% | -645.65% | -552.06% | -475.20% | -412.99% |
| Average Basic Shares Outstanding | 43.05% | 36.31% | 22.70% | 9.29% | 3.13% |
| Average Diluted Shares Outstanding | 43.05% | 36.31% | 22.70% | 9.29% | 3.13% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |